Response predictors to cardiac resynchronization therapy in chronic heart failure: a 10-year-cardiovascular center

Juan C Plata-Corona1, Fabio Solis-Jiménez1, Maximiliano Flores-Flamand1

  • 1Department of Clinical Cardiology.

PubMed

Insights

Predicting cardiac resynchronization therapy (CRT) success is crucial. Left bundle branch block, specific echocardiographic measures, and ventricular volumes independently predict positive CRT response in heart failure patients.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Cardiac Electrophysiology

Background:

  • Cardiac resynchronization therapy (CRT) is established for heart failure with reduced ejection fraction.
  • Clinical trials confirm CRT's benefits on mortality, hospitalizations, and quality of life.

Purpose of the Study:

  • Identify clinical, electrocardiographic, and echocardiographic predictors of CRT response.
  • Improve patient selection for CRT.

Main Methods:

  • Retrospective observational study of 102 heart failure patients undergoing CRT.
  • Response defined by improved NYHA class and LVEF recovery (≥5%).
  • Analysis of baseline and post-CRT clinical and echocardiographic data.

Main Results:

  • 50% of patients were responders.
  • Responders had wider QRS, lower baseline LVEF, and RV fractional area change.
  • Left bundle branch block (LBBB), LVEDV, TAPSE, and pre-ejection time difference predicted CRT response.

Conclusions:

  • LBBB, TAPSE, LVEDV, and pre-ejection time difference are independent predictors of CRT response.
  • These variables can aid in optimizing CRT patient selection.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
796
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338